M
MeiraGTx Holdings plc D
D
MGTX
7.50000
USD
0.56
(8.07%)
مغلق
حجم التداول
26,500
الربح لكل سهم
-2
العائد الربحي
-
P/E
-3
حجم السوق
602,740,193
الأخبار المقالات
العنوان: MeiraGTx Holdings plc
القطاع: Healthcare
الصناعة: Biotechnology
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.